Median progression-free survival (mPFS) was 15.1 months, and the confirmed overall response rate (cORR) increased to 45% for the 100mg QD (once daily) tablet cohort in an updated analysis of the ...
In various physiological and pathological contexts—including cancer, tissue ischemia, and stem cell homeostasis—cells are often exposed to a graded hypoxic continuum ranging from mild to moderate to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results